Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,972.00
(
0.39%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.16
(
0.53%
)
Bitcoin
76,572.81
(
0.90%
)
News Focus
News Focus
Post# of 257431
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: crudeoil24 post# 230558

Wednesday, 02/17/2021 10:33:41 AM

Wednesday, February 17, 2021 10:33:41 AM

Post# of 257431
VIR, GSK expand COVID collaboration to flu:

http://www.globenewswire.com/news-release/2021/02/17/2176979/0/en/GSK-and-Vir-Biotechnology-Expand-Coronavirus-Collaboration-to-Advance-New-Therapeutics-for-Influenza-and-Other-Respiratory-Viruses.html

GSK is paying VIR $225M in cash up-front and is making a new $120M investment in VIR stock.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today